| Published in Scientific Journal Molecular Aspects of Medicine SALT LAKE CITY, Nov. 10, 2011 (GLOBE NEWSWIRE) -- LifeVantage Corporation (OTCBB:LFVN), the maker of science-based solutions to oxidative stress, announced today that a new peer-reviewed study involving its flagship product, Protandim ® , has been published in the scientific journal Molecular Aspects of Medicine . The new paper takes a historical look at the field of biological antioxidants and oxidative stress, examines gene regulation...continued LFVN Drugs Healthcare barrier |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment